Компания Eurofins расширила мощности по производству высокоактивных фармацевтических субстанций в Миссиссоге

MISSISSAUGA, Ontario — Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga. The expanded laboratories are designed to support the growing demand for enhanced flexibility as part of process development, scale-up, and manufacturing activities for non-high potent and high potent programs. Together, the suites cover 627 square feet. They are equipped with walk-in fume hoods capable of supporting up to 100L glass reactors and utilise a flexible design so that specialised equipment such as isolators, glove boxes, and lyophilizers can fulfill project requirements as needed, enabling efficient execution of a wide range of non-high potent and high potent programs. The laboratories are further supported by an additional dedicated analytical laboratory and an adjacent GMP warehouse, creating an integrated environment that streamlines development workflows, analytical support, material management, and manufacturing readiness.